References
- Gottlieb SS, McCarter RJ, Vogel RA: Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339:489, 1998
- Flaker GC et al: Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Am Heart J 137:307, 1999
- Havranek EP et al: Determinants of mortality in elderly patients with heart failure: The role of angiotensin-converting enzyme inhibitors. Arch Intern Med 158:2024,1998
- Sueta CA et al: Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol 83:1303, 1999
- Mendelson G, Aronow WS: Underutilization of warfarin in older patients with chronic nonvalvular atrial fibrillation at high risk for developing stroke. J Am Geriatr Soc 46:1423,1998
- Mendelson G, Aronow WS: Underutilization of measurement of serum low-density lipoprotein cholesterol levels and of lipid-lowering therapy in older patients with manifest atherosclerotic disease. J Am Geriatr Soc 46:1128, 1998
- Philbin EF, Santella RN, Rocco TA Jr: Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction. J Am Geriatr Soc 47:302,1999
- Guyatt GH et al: Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group. JAMA 281:1836, 1999
- Maseri A: Evidence-based medicine: Progress but not a final solution (editorial). Clin Cardiol 21:463, 1998